Copyright
©2013 Baishideng Publishing Group Co.
World J Crit Care Med. Nov 4, 2013; 2(4): 40-47
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.40
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.40
Table 1 Survival and cumulative incidence of neurologic complications by age and indication for extracorporeal membrane oxygenation (Extracorporeal Life Support Organization 2013)
| Cumulative survival to discharge or transfer | 2012 survival to discharge or transfer | Clinical seizures | Central nervous system hemorrhage | |
| Neonatal | ||||
| Respiratory | 75% | 69% | 9.20% | 7.10% |
| Cardiac | 40% | 45% | 7.20% | 11.10% |
| ECPR | 39% | |||
| Pediatric | ||||
| Respiratory | 56% | 58% | 5.70% | 6.00% |
| Cardiac | 49% | 55% | 6.80% | 4.90% |
| ECPR | 41% | |||
| Adult | ||||
| Respiratory | 55% | 57% | 1.10% | 4.00% |
| Cardiac | 39% | 39% | 2.00% | 2.00% |
| ECPR | 28% | |||
- Citation: Mehta A, Ibsen LM. Neurologic complications and neurodevelopmental outcome with extracorporeal life support. World J Crit Care Med 2013; 2(4): 40-47
- URL: https://www.wjgnet.com/2220-3141/full/v2/i4/40.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v2.i4.40